Related Experiment Video

Updated: Sep 29, 2026

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
08:30

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Published on: May 10, 2022

CD26: an expanding role in immune regulation and cancer

N H Dang1, C Morimoto

  • 1Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Box 429, 1515 Holcombe Boulevard, Houston, Texas 77030, USA. nhdang@mail.mdanderson.org

Histology and Histopathology
|October 10, 2002
PubMed

Insights

CD26, a cell surface glycoprotein, plays a key role in immune regulation and cancer. Research explores its potential as a therapeutic target for T cell malignancies and other cancers.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • CD26, also known as dipeptidyl peptidase IV (DPPIV), is a cell surface glycoprotein with diverse biological functions.
  • Its role extends beyond basic cell surface expression to active participation in cellular processes.

Purpose of the Study:

  • To review the multifaceted biology of CD26, focusing on its roles in immune regulation and cancer.
  • To explore CD26's interactions with other cellular molecules and its implications in disease.
  • To evaluate CD26 as a potential therapeutic target for hematological malignancies.

Main Methods:

  • Literature review of studies on CD26 biology, immune function, and cancer association.
  • Analysis of research on CD26 interactions with cellular molecules.
  • Examination of studies investigating CD26 as a therapeutic target.

Main Results:

  • CD26/DPPIV is crucial for T cell activation and chemokine regulation, highlighting its immune modulatory functions.
  • Physical associations between CD26 and other cellular molecules have significant functional and clinical implications.
  • CD26 is implicated in the pathogenesis and progression of various human cancers, including solid tumors and hematological malignancies.

Conclusions:

  • CD26 is a critical molecule in immune regulation and cancer biology.
  • Understanding CD26 interactions provides insights into disease mechanisms.
  • CD26 represents a promising molecular target for novel therapeutic strategies against T cell lymphoid and other hematological malignancies.

More Related Videos

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...